Correlation Of Ki67 And Her2 Expression With Histopathological Grading Of Breast Cancer
DOI:
https://doi.org/10.64252/8nhm2e25Keywords:
Ki67 expression, HER2, histopathological grading, breast cancerAbstract
Breast cancer is one of the most common types of cancer in women worldwide, including in Indonesia. Biomarker assessments, such as Ki-67 and HER2, have significant prognostic and predictive value in determining tumour aggressiveness and guiding therapy options. Histopathological grading reflects the degree of cancer cell differentiation and plays a role in determining prognosis. This study aimed to determine the correlation between Ki67 and HER2 expression and histopathological grading of breast cancer in women. Methods: This study used an observational analytical design with a cross-sectional approach. Samples were taken from female patients diagnosed with invasive breast cancer who underwent biopsy or mastectomy at one national referral hospital. Ki-67 and HER2 expression were analysed using immunohistochemistry, while histopathological grading was assessed using the Nottingham Prognostic Index (NPI) grading system. Results: The most cases of breast cancer were in the 51-60 years age group, namely 42 respondents (29.6%). Grade 3 breast cancer was the most common, namely 63 respondents (44.5%). Estrogen receptor (ER) results were positive in 89 respondents (62.7%), and negative in 53 respondents (37.3%). In the progesterone receptor (PR) positive results, 81 respondents (57%) were identified, while 61 respondents (43%) had negative results. HER2 Neu results were positive in 54 respondents (38%), negative in 62 respondents (43.7%), and equivocal in 26 respondents (18.3%). Ki-67 was most frequently positive in results/proliferation >20%, with 80 respondents (62.5%), and in negative results/proliferation <20%, with 46 respondents (35.9%). There were 2 respondents (1.6%) in whom Ki-67 was not detected. Ki67 expression in histopathological grading of breast cancer, especially in grade 3, with a p-value of 0.002 (p <0.005) and in grade 2 with a value of 0.003. In contrast, the p-value results for HER2 on histopathological grading of breast cancer did not show significant results in grades 1 (p = 0.051), 2 (p = 0.006), and 3 (p = 0.005), with p-values greater than 0.005. Conclusion: A significant correlation exists between Ki-67 and histopathological grading, whereas no significant correlation is found between HER2 and histopathological grading of breast cancer.